Indian Cancer Drug Manufacturer to Pay $50 Million for Concealing and Destroying Records in Advance of FDA Inspection

FDA OCI, Fresenius, FKOL, fines, forfeiture, $50 million, guilty plea, conceal records, destroy records, FDA inspection, compliance and ethics program, Kalyani, West Bengal, India, manufacture, active pharmaceutical ingredients, APIs, noncompliant practices, deleted spreadsheets,
Source: Office of Criminal Investigations (OCI) Press Releases - Category: Medical Law Authors: Source Type: news